Contact
Please use this form to send email to PR contact of this press release:
Sienna Biopharmaceuticals Announces Pivotal Trials with SNA-001 in Acne Did Not Meet Primary and Secondary Endpoints
TO:
Please use this form to send email to PR contact of this press release:
Sienna Biopharmaceuticals Announces Pivotal Trials with SNA-001 in Acne Did Not Meet Primary and Secondary Endpoints
TO: